Patent details

EP1250146 Title: USE OF BOTULINUM TOXINS FOR TREATING DIABETES

Basic Information

Publication number:
EP1250146
PCT Application Number:
PCT/US/2001/002273
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019032622
PCT Publication Number:
WO/2001/054711
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF BOTULINUM TOXINS FOR TREATING DIABETES
French Title of Invention:
UTILISATION DE TOXINES BOTULINUM DANS LE TRAITEMENT DU DIABETE
German Title of Invention:
VERWENDUNG VON BOTULINUM-TOXIN ZUR BEHANDLUNG VON DIABETES
SPC Number:

Dates

Filing date:
24/01/2001
Grant date:
02/01/2004
EP Publication Date:
02/01/2004
PCT Publication Date:
02/08/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/10/2002
EP B1 Publication Date:
02/01/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/01/2004
Expiration date:
24/01/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/01/2001
 
 

Name:
Allergan Inc.
Address:
2525 Dupont Drive,, Irvine, CA 92612, United States (US)

Inventor

Name:
DONOVAN Stephen
Address:
United States (US)

Priority

Priority Number:
491420
Priority Date:
26/01/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/16;
Filing date Document type Number of pages